12 results
8-K
EX-2.1
LRMR
Larimar Therapeutics Inc
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
OMITTED
NO FINANCIAL ADVISORS
TRANSACTIONS WITH AFFILIATES
PRIVACY AND DATA SECURITY
ACCREDITED INVESTOR STATUS
NO OTHER REPRESENTATIONS OR WARRANTIES … ADVISORS
VALID ISSUANCE; NO BAD ACTOR
PRIVACY AND DATA SECURITY
REGULATORY FILINGS
EXCHANGE ACT REGISTRATION
NO OTHER REPRESENTATIONS OR WARRANTIES
DEFA14A
EX-2.1
LRMR
Larimar Therapeutics Inc
18 Dec 19
Additional proxy soliciting materials
8:11am
OMITTED
NO FINANCIAL ADVISORS
TRANSACTIONS WITH AFFILIATES
PRIVACY AND DATA SECURITY
ACCREDITED INVESTOR STATUS
NO OTHER REPRESENTATIONS OR WARRANTIES … ADVISORS
VALID ISSUANCE; NO BAD ACTOR
PRIVACY AND DATA SECURITY
REGULATORY FILINGS
EXCHANGE ACT REGISTRATION
NO OTHER REPRESENTATIONS OR WARRANTIES
8-K/A
EX-99.2
LRMR
Larimar Therapeutics Inc
26 Jun 20
Other Events
5:08pm
in an economic downturn that could have a material adverse effect on our business and prospects.
Compliance with global privacy and data security requirements … operate has established its own data security and privacy frameworks with which we must comply. For example, the European Union’s General Data Protection
8-K
EX-10.1
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
party with respect to the material Intellectual Property of the Company or its Subsidiaries.
(b)Privacy and Data Security. The Company has complied
8-K
EX-10.1
LRMR
Larimar Therapeutics Inc
21 May 21
Entry into a Material Definitive Agreement
9:30am
) Privacy and Data Security. The Company has complied with all applicable Privacy Laws relating to privacy, security, collection or use of Personal
PREM14A
igdh4azeh40m8wex
6 Mar 20
Preliminary proxy related to merger
5:32pm
DEFM14A
f86hi
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
332q8al w0k56x
10 Apr 20
Preliminary revised proxy
4:38pm
- Prev
- 1
- Next